Published in
Taylor & Francis (Routledge), Health Care for Women International, 10(36), p. 1072-1080
DOI: 10.1080/07399332.2014.948627
Links
Tools
Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother
Journal article published in 2014 by
Yara Dadalti Fragoso 
,
Tarso Adoni,
Soniza Vieira Alves-Leon,
Nerio Dutra Azambuja,
Amilton Antunes Barreira,
Joseph Bruno Bidin Brooks,
Denise Sisteroli Diniz Carneiro,
Margarete J. Carvalho,
Rinaldo Claudino,
Elizabeth Regina Comini-Frota,
Renan Barros Domingues,
Alessandro Finkelsztejn,
Paulo Diniz Gama ,
Maria Cristina Brandao Giacomo,
Sidney Gomes
and other authors.
,
Tarso Adoni,
Soniza Vieira Alves-Leon,
Nerio Dutra Azambuja,
Amilton Antunes Barreira,
Joseph Bruno Bidin Brooks,
Denise Sisteroli Diniz Carneiro,
Margarete J. Carvalho,
Rinaldo Claudino,
Elizabeth Regina Comini-Frota,
Renan Barros Domingues,
Alessandro Finkelsztejn,
Paulo Diniz Gama ,
Maria Cristina Brandao Giacomo,
Sidney Gomes
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Multiple sclerosis (MS) is a chronic neurological immune-mediated disease that can worsen in the post-partum period. There is no consensus on the use of immunoglobulin for prevention of disease relapses after delivery. The authors of the present paper have shown that the controversial beneficial effect of immunoglobulin given immediately after birth could not be observed in patients with MS.